Natera to supply MRD testing for Kupando skin cancer trial
Go back to Natera to supply MRD testing for Kupando skin cancer trial| (NASDAQ: NTRA) | Delayed: 361.45 -4.86 (1.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $366.31 | 52 Week High | $13.80 | |||
| Open | $365.78 | 52 Week Low | $6.52 | |||
| Day High | $367.00 | P/E | N/A | |||
| Day Low | $360.72 | EPS | $0.00 | |||
| Volume | 317,928 | |||||
